Page last updated: 2024-10-16

gamma-aminobutyric acid and Muscular Dystrophy, Facioscapulohumeral

gamma-aminobutyric acid has been researched along with Muscular Dystrophy, Facioscapulohumeral in 1 studies

gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.

Muscular Dystrophy, Facioscapulohumeral: An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Lazzaro, V1
Oliviero, A1
Tonali, PA1
Felicetti, L1
De Marco, MB1
Saturno, E1
Pilato, F1
Pescatori, M1
Dileone, M1
Pasqualetti, P1
Ricci, E1

Other Studies

1 other study available for gamma-aminobutyric acid and Muscular Dystrophy, Facioscapulohumeral

ArticleYear
Changes in motor cortex excitability in facioscapulohumeral muscular dystrophy.
    Neuromuscular disorders : NMD, 2004, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Diazepam Binding Inhibitor; Electric Stimulation; Epilepsy; gamma-Aminobutyric Ac

2004